Carisma Therapeutics Inc
2 clinical trials · Sponsor
◉ Watch Carisma Therapeutics Inc
| Record | Firm | Date |
|---|---|---|
| CAR-monocytes for the Treatment of HER2 Overexpressing Solid Tumors (NCT06254807) | Carisma Therapeutics Inc | 2024-01-08 |
| CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors (NCT04660929) | Carisma Therapeutics Inc | 2021-02-02 |
Track Carisma Therapeutics Inc automatically
Every clearance here is in the API, with alerts when new ones post.